Chronic Kidney Disease after Nonmyeloablative Stem Cell Transplantation in Adults

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 403-408

  Kersting, Sabina ^a   Verdonck, Leo F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chronic kidney disease; Hematopoietic stem cell transplantation; Stem cell transplantation nephropathy; Survival

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GENDER BIAS; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OVERALL SURVIVAL; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT VS HOST DISEASE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 40649127729     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.12.495     Document Type: Article

References (37)

1. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101 (2003) 1620-1629
2. Borg M., Hughes T., Horvath, et al. Renal toxicity after total body irradiation. Int J Radiat Oncol Biol Phys 54 (2002) 1165-1173
3. Cohen E.P., Piering W.F., Kabler-Babbitt C., and Moulder J.E. End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79 (1998) 408-412
4. Deconinck E., Kribs M., Rebibou J.M., et al. Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation. Haematologica 90 (2005) 569-570
5. Delgado J., Cooper N., Thomson K., et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 75-83
6. Imai H., Oyama Y., Miura A.B., et al. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 36 (2000) 474-480
7. Leblond V., Sutton L., Jacquiaud C., et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 6 (1995) 1661-1665
8. Miralbell R., Bieri S., Mermillod B., et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 14 (1996) 579-585
9. Miralbell R., Sancho G., Bieri S., et al. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Int J Radiat Oncol Biol Phys 58 (2004) 809-816
10. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
11. Hingorani S., Guthrie K.A., Schoch G., et al. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39 (2007) 223-229
12. Kersting S., Hené R.J., Koomans H.A., and Verdonck L.F. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 1169-1175
13. Chappell M.E., Keeling D.M., Prentice H.G., and Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?. Bone Marrow Transplant 3 (1988) 339-347
14. Cohen E.P., Lawton C.A., Moulder J.E., et al. Clinical course of late-onset bone marrow transplant nephropathy. Nephron 64 (1993) 626-635
15. Cohen E.P., Lawton C.A., and Moulder J.E. Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 70 (1995) 217-222
16. Cohen E.P. Radiation nephropathy after bone marrow transplantation. Kidney Int 58 (2000) 903-918
17. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 17 (2006) 1995-2005
18. Juckett M., Perry E.H., Daniels B.S., and Weisdorf D.J. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 7 (1991) 405-409
19. Kersting S., and Verdonck L.F. Stem cell transplantation nephropathy: a report of six cases. Biol Blood Marrow Transplant 13 (2007) 638-643
20. Lawton C.A., Cohen E.P., Barber-Derus S.W., et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67 (1991) 2795-2800
21. Lawton C.A., Barber-Derus S.W., Murray K.J., et al. Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. Int J Radiat Oncol Biol Phys 23 (1992) 681-686
22. Lawton C.A., Cohen E.P., Murray K.J., et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 20 (1997) 1069-1074
23. Rabinowe S.N., Soiffer R.J., Tarbell N.J., et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 77 (1991) 1837-1844
24. Zenz T., Schlenk R.F., Glatting G., et al. Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation. J Nucl Med 47 (2006) 278-286
25. Culleton B.F., Larson M.G., Evans J.C., et al. Prevalence and correlates of elevated serum creatinine levels-the Framingham heart study. Arch Int Med 159 (1999) 1785-1790
26. Weiss A.S., Sandmaier B.M., Storer B., et al. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6 (2006) 89-94
27. Parikh C.R., McSweeney P.A., Korular D., et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62 (2002) 566-573
28. Parikh C.R., McSweeney P., and Schrier R.W. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67 (2005) 1999-2005
29. Thomas E.D., Storb R., Clift R.A., et al. Bone-marrow transplantation (second of two parts). N Engl J Med 292 (1975) 895-902
30. Putter H., Fiocco M., and Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26 (2007) 2389-2430
31. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
32. Fox C.S., Larson M.G., Leip E.P., et al. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
33. Buemi M., Nostro L., Aloisi C., et al. Kidney aging: from phenotype to genetics. Rejuvenat Res 8 (2005) 101-109
34. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
35. Bloom R.D., and Doyle A.M. Kidney disease after heart and lung transplantation. Am J Transplant 6 (2006) 671-679
36. Gruss E., Bernis C., Tomas J.F., et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15 (1995) 473-479
37. Tedoriya T., Keogh A.M., Kusano K., et al. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 21 (2002) 976-982